BURGESS ERNEST G III 4
4 · NATIONAL HEALTHCARE CORP · Filed Aug 11, 2022
Insider Transaction Report
Form 4
BURGESS ERNEST G III
Director
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2022-08-10−2,500→ 5,000 totalExercise: $61.90From: 2018-05-03Exp: 2023-05-02→ Common Stock (7,500 underlying) - Exercise/Conversion
Shares of Common Stock
2022-08-10$61.90/sh+2,500$154,750→ 94,144 total
Holdings
- 7,500
Option to Purchase Common Stock
Exercise: $72.92From: 2017-05-09Exp: 2022-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).